PyloPlus Urea Breath Test System
Arj Medical, Inc. · Decision date Sep 16, 2025
What did the FDA decide?
FDA records P170022/S008 as a supplement to PMA P170022, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Sep 16, 2025.
FDA approval order statement
consolidation of all manufacturing activities to a single location and to increase a manufacturing maximum batch size
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Microbiology
- Decision date
- Sep 16, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P170022/S008
- Regulatory pathway
- PMA supplement
- Applicant
- Arj Medical, Inc.
- Product code
- OZA
- Decision code
- OK30
- Decision date
- Sep 16, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Test, urea adult and pediatric (breath),.
- Applicant
- Arj Medical, Inc.
- Product code
- OZA
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P170022/S008 received
Application receipt date recorded by FDA.
P170022/S008 · FDA decision
30-Day Notice
P170022/S007 · Related supplement
PyloPlus UBT System
Timeline entries are records held by MedtechLedger for P170022. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P170022
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
PyloPlus UBT SystemP170022/S007 | Arj Medical, Inc. | PMA supplement | Feb 5, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Arj Medical, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 209 State St. E., Oldsmar, FL, 34677
Sources and methodology
- Original FDA record: P170022/S008
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records